经肝动脉化疗栓塞联合射频消融术对原发性肝癌的近期效果评价

目的 探索经肝动脉化疗栓塞联合射频消融术对原发性肝癌的近期效果.方法 选取2015年3月11日至2017年11月30日期间我院原发性肝癌50例患者,随机化分组,即25例每组,对照组和观察组分别采用肝动脉化疗栓塞治疗和经肝动脉化疗栓塞联合射频消融术治疗.结果 观察组患者总有效率(88.00%)、不良反应发生率(20.00%)、病灶大小(2.85±1.65)cm、病灶数目(1.14±0.75)个、AFP(125.44±21.86)ug/L均优于对照组(P<0.05).结论 对原发性肝癌患者实施经肝动脉化疗栓塞联合射频消融术治疗效果显著.

Objective to explore the recent effects of combined radiofrequency ablation with hepatic arterial chemoembolization in the treatment of primary liver cancer.Methods select on March 11,2015 to November 30,2017,our hospital during the period of 50 cases of primary liver cancer patients,randomized groups,namely,25 cases in each group,control group and observation group with hepatic artery embolization and chemotherapy via hepatic artery embolism chemotherapy with radiofrequency ablation therapy.Results the total effective rate observation group of patients(88.00%),the incidence of adverse reactions(20.00%),and the size of the lesions,(2.85±1.65)cm,number of lesions(1.14±0.75)and AFP(125.44±21.86)ug/L were better than control group(P<0.05).Conclusion the treatment of patients with primary hepatocellular carcinoma with hepatic arterial chemoembolization combined with radiofrequency ablation is effective.